Drug industry is unwilling to run trials in childrenBMJ 2000; 320 doi: https://doi.org/10.1136/bmj.320.7246.1362/a (Published 20 May 2000) Cite this as: BMJ 2000;320:1362
View Full Text
- Zosia Kmietowicz
Few drug companies are willing to undertake clinical trials in children voluntarily, according to a survey carried out by Britain's Consumers' Association. A change in the regulations governing drug licences may be the only option for ensuring that products used in children are safe and effective.
As part of its campaign to ensure that all drugs used in children are subject to the same regulatory procedures as those used in adults, the association wrote to all 79 members of the …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.